Quality Of Life Of Atrial Fibrillation Patients Undergoing Anticoagulation Therapy | 13352
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Quality of life of atrial fibrillation patients undergoing anticoagulation therapy

International Summit on Clinical Pharmacy & Dispensing

Laila Mahmoud Matalqah, Syed Azhar Syed Sulaiman, Mohamed Azmi Hassali and Khaldoon Mahmoud Radaideh

Accepted Abstracts: Clinic Pharmacol Biopharmaceut

DOI: 10.4172/2167-065X.S1.004

Objectives: This study sought to evalute the quality of life (QoL) among patients undergoing anticoagultaion therapy and to identify the factors impacting their health. Methods: A cross sectional descriptive study was undertaken with atrial fibrillation patients undergoing anticoagulation therapy. A convienience sample of 339 patients were identified at Anticoagulation Clinics of two public hospitals in Penang, Malaysia. A bilingual specific instrument; Duke Anticoagulation Satisfaction Scale (DASS) and a generic instrument; the European Quality of Life scale (EQ-5D) were used for data collection. ANOVA or t-test were used to detect the differences between continuous variables among the groups. Results: Patients on warfarin therapy showed good perception of QoL. The DASS results presented an average score of 70.8 (?19.8), EQ-5D descriptive mean average score was 0.80 (?0.26) and EQ-VAS mean score was 63.3 (?16.3). However, this perception was influenced positively by age, education level, and occupation and negatively by sex gender and previous hemorrhagic event. Conclusion: warfarin therapy is not usually associated with a significant decrease in perceived health, unless a bleeding episode has occurred.